Gene · 5499
NIH grants1,909
NIH grants whose papers are about the gene, through NIH's grant-paper links.
61 to 80 of 1,909
Download this page as JSON| Grant | Title | PPP1CA papers | Newest fiscal year |
|---|---|---|---|
| R01HL058758 | Molecular basis of ILK-mediated cell adhesion | 2 | 2025 |
| R01NS124666 | Serine/Threonine Phosphatases in Neurological Diseases | 2 | 2025 |
| R35CA253095 | Innate immune sensors, inflammasomes, and inflammasome-mediated processes in cancer | 2 | 2025 |
| R35GM118112 | Chemical probes to decipher PAD biology | 2 | 2025 |
| R35GM128624 | Unravelling Membrane Protein-Lipid Interactions using Nanodiscs and Mass Spectrometry | 2 | 2025 |
| R35GM131766 | Designing a new class of fluorescent reporters for imaging dynamic cell signaling in live animals | 2 | 2025 |
| R37AI087846 | Regulation of Host Innate Immunity Against Viral Infection | 2 | 2025 |
| R37AI101935 | Inflammatory Caspases in Innate Immunity and Inflammation | 2 | 2025 |
| U19AI142733 | Modulation of Lung Immune Responses to Viral Infection | 2 | 2025 |
| U54GM138062 | Center for Pacific Innovations, Knowledge, and Opportunities (PIKO) | 2 | 2025 |
| U54MD007601 | Ola HAWAII | 2 | 2025 |
| UL1TR002345 | Washington University Institute of Clinical and Translational Sciences | 2 | 2025 |
| ZIAAG000948 | Leucine rich repeat kinase 2 and dominantly inherited Parkinson disease | 2 | 2025 |
| ZIATR000018 | Drug Repurposing Screening for Rare and Neglected Diseases | 2 | 2025 |
| D43TW008652 | Mali-Guinea Research Leadership Training Program for Sustainable control and elimination of Malaria and Neglected tropical diseases | 1 | 2025 |
| D43TW010319 | Microbiology and Immunology Training for HIV and HIV-Related Research in Uganda (MITHU) | 1 | 2025 |
| D43TW011818 | Mali-Guinea Emerging Infectious Disease Research Training Program (Mali-Guinea EID-RTP) | 1 | 2025 |
| I01BX003635 | Inflammatory and Fibrotic Responses to Malondialdehyde-Acetaldehyde Adducts in Rheumatoid Arthritis | 1 | 2025 |
| I01BX004293 | CYP11A1-derived secosteroids as therapeutic agents in UVB induced skin cancer | 1 | 2025 |
| P01AI063302 | The intersection of innate and adaptive immunity to intracellular pathogens | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5499/grants?page=4